Follow Us:
Opioid 101:
Contact us:
Thank you! We’ve sent you an email to confirm your address.
New heroin use sharply down in 2017, undercutting common narrative
The number of new heroin users fell by more than half in 2017, according to the latest national drug survey, which was unveiled Friday. “One of the most important findings,” said SAMHSA chief Elinore McCance-Katz in announcing the results in a webcast, “is the very steep decline in new users of heroin from 2016.” New initiates to that drug dropped from 170,000 to 81,000.
Sniffer dogs in the age of fentanyl
America’s 50,000 police dogs are foot soldiers in the fight against illegal drugs. But synthetic opioids like fentanyl and carfentanil are so strong that, unlike other drugs, they can damage and even kill dogs.
FDA Meets With Google, Facebook and others to stanch online opioid sales
The FDA held a summit with representatives of corporate Internet giants today to discuss further collaboration to stanch online opioid sales.
200 a Day Now Dying of Overdose. Chris Christie’s New Jersey Had Nation’s Second Worst Hike in Deaths
According to the CDC’s latest statistics, about 200 Americans are now dying each day from drug overdoses—the first time the numbers have breached that benchmark.
News Roundup: May 24, 2018: A Visit to a Chinese Fentanyl Lab
Bloomberg reporters track down an "illicit" fentanyl lab operator in China, but Chinese authorities say he isn't breaking the law.  
How Synthetic Opioids—New and Lethal—Are Tested and Trafficked on the Darknet
Last month a project called eDarkTrends posted an alert on the National Drug Early Warning System
Drug Policy Expert Robert DuPont: The Opioid Crisis is Now About Synthetics and Polydrug Use
Psychiatrist Robert L. DuPont, MD, has been campaigning against opioid addiction for half a century.
An Algorithmic Breakthrough In the Fight Against Illicit Opioid Trafficking
Behind the deadliest and most lucrative sector of opioid trafficking, a global cat-and-mouse game is playing out each day—among chemists.
Q&A (Pt 2): Addiction Expert Discusses Hate Mail and Why Opioids are “Lousy” Drugs for Pain
Andrew Kolodny is co-director of the Opioid Policy Research Collaborative of the Heller School for Social Policy and Management at Brandeis University.
More from Opioid Watch